Gastroenterology

A systematic evaluation is essential to differentiate among these conditions and guide appropriate care across clinical settings.

Patients with celiac disease or other gluten-sensitivity disorders have a documented increase in objective findings of systemic autoimmune disease and autoantibodies.

Like obesity, dyslipidemia, hypertension, and type 2 diabetes mellitus, metabolic dysfunction–associated steatotic liver disease is ubiquitous; however, awareness of it remains low.

Current efforts are focused on better identifying patients at high risk for Barrett esophagus as candidates for endoscopic screening and developing less invasive and cheaper detection methods.

Screening for MASH follows a stepwise, sequential approach, beginning with calculation of the fibrosis-4 index

P-CABs provide rapid, potent, predictable acid suppression without the need for timing around meals, but their current role is focused and limited.